American Journal of Ophthalmology
Volume 139, Issue 5 , Pages 802-806 , May 2005

Relation Between Reduction of Foveal Thickness and Visual Acuity in Diabetic Macular Edema Treated With Intravitreal Triamcinolone

  • Jörgen Larsson, MD, PhD

      Affiliations

    • Department of Clinical Ophthalmology, Save Sight Institute, University of Sydney, Sydney, Australia
    • Department of Ophthalmology, Lund University Hospital, Lund, Sweden.
    • Corresponding Author InformationInquiries to Jorgen Larsson, MD, PhD, Save Sight Institute, GPO Box 4337, Sydney NSW 2001, Australia; fax: 02 93827318
  • ,
  • Meidong Zhu, MD, PhD

      Affiliations

    • Department of Clinical Ophthalmology, Save Sight Institute, University of Sydney, Sydney, Australia
  • ,
  • Florian Sutter, MD

      Affiliations

    • Department of Clinical Ophthalmology, Save Sight Institute, University of Sydney, Sydney, Australia
  • ,
  • Mark C. Gillies, MD, PhD

      Affiliations

    • Department of Clinical Ophthalmology, Save Sight Institute, University of Sydney, Sydney, Australia

,Accepted 20 December 2004.

References 

  1. Early Treatment Diabetic Retinopathy Study Research Group . Early photocoagulation for diabetic retinopathy. ETDRS report number 9 . Ophthalmology . 1991;98:766–785
  2. Bakri SJ , Beer PM . The effect of intravitreal triamcinolone acetonide on intraocular pressure . Ophthalmic Surg Lasers Imaging . 2003;34:386–390
  3. Gillies MC , Simpson JM , Billson FA , et al.   Safety of an intravitreal injection of triamcinolone (results from a randomized clinical trial) . Arch Ophthalmol . 2004;122:336–340
  4. Jonas JB , Kreissig I , Degenring R . Intraocular pressure after intravitreal injection of triamcinolone acetonide . Br J Ophthalmol . 2003;87:24–27
  5. Young S , Larkin G , Branley M , Lightman S . Safety and efficacy of intravitreal triamcinolone for cystoid macular edema in uveitis . Clin Experiment Ophthalmol . 2001;29:2–6
  6. Degenring RF , Kreissig I , Jonas JB . [Intraocular triamcinolone for diffuse diabetic macular edema] . Ophthalmologe . 2004;101:251–254
  7. Jonas JB , Sofker A . Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema . Am J Ophthalmol . 2001;132:425–427
  8. Jonas JB , Degenring R . [Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular edema] . Klin Monatsbl Augenheilkd . 2002;219:429–432
  9. Jonas JB , Kreissig I , Sofker A , Degenring RF . Intravitreal injection of triamcinolone for diffuse diabetic macular edema . Arch Ophthalmol . 2003;121:57–61
  10. Martidis A , Duker JS , Greenberg PB , et al.   Intravitreal triamcinolone for refractory diabetic macular edema . Ophthalmology . 2002;109:920–927
  11. Massin P , Audren F , Haouchine B , et al.   Intravitreal triamcinolone acetonide for diabetic diffuse macular edema (preliminary results of a prospective controlled trial) . Ophthalmology . 2004;111:218–224
  12. Wilson CA , Berkowitz BA , Sato Y , Ando N , Handa JT , de Juan E . Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation . Arch Ophthalmol . 1992;110:1155–1159
  13. Alldredge CD , Garretson BR . Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis . Retina . 2003;23:113–116
  14. Antcliff RJ , Spalton DJ , Stanford MR , Graham EM , ffytche TJ , Marshall J . Intravitreal triamcinolone for uveitic cystoid macular edema (an optical coherence tomography study) . Ophthalmology . 2001;108:765–772
  15. Benhamou N , Massin P , Haouchine B , Audren F , Tadayoni R , Gaudric A . Intravitreal triamcinolone for refractory pseudophakic macular edema . Am J Ophthalmol . 2003;135:246–249
  16. Danis RP , Ciulla TA , Pratt LM , Anliker W . Intravitreal triamcinolone acetonide in exudative age-related macular degeneration . Retina . 2000;20:244–250
  17. Ip M , Kahana A , Altaweel M . Treatment of central retinal vein occlusion with triamcinolone acetonide (an optical coherence tomography study) . Semin Ophthalmol . 2003;18:67–73
  18. Jonas JB , Kreissig I , Hugger P , Sauder G , Panda-Jonas S , Degenring R . Intravitreal triamcinolone acetonide for exudative age related macular degeneration . Br J Ophthalmol . 2003;87:462–468
  19. Jonas JB , Akkoyun I , Budde WM , Kreissig I , Degenring RF . Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration . Arch Ophthalmol . 2004;122:218–222
  20. Karacorlu M , Ozdemir H , Karacorlu S . Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular edema . Acta Ophthalmol Scand . 2003;81:648–652
  21. Park CH , Jaffe GJ , Fekrat S . Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion . Am J Ophthalmol . 2003;136:419–425
  22. Rechtman E , Danis RP , Pratt LM , Harris A . Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration . Br J Ophthalmol . 2004;88:344–347
  23. Sutter FK , Gillies MC . Intravitreal triamcinolone for radiation-induced macular edema . Arch Ophthalmol . 2003;121:1491–1493
  24. Otani T , Kishi S , Maruyama Y . Patterns of diabetic macular edema with optical coherence tomography . Am J Ophthalmol . 1999;127:688–693
  25. Antoszyk AN , Gottlieb JL , Machemer R , Hatchell DL . The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization . Graefes Arch Clin Exp Ophthalmol . 1993;231:34–40
  26. Stahl JH , Miller DB , Conway BP , Campochiaro PA . Dexamethasone and indomethacin attenuate cryopexy. Induced breakdown of the blood-retinal barrier . Graefes Arch Clin Exp Ophthalmol . 1987;225:418–420
  27. Lieth E , Gardner TW , Barber AJ , Antonetti DA . Retinal neurodegeneration (early pathology in diabetes) . Clin Experiment Ophthalmol . 2000;28:3–8

PII: S0002-9394(04)01597-1

doi: 10.1016/j.ajo.2004.12.054

American Journal of Ophthalmology
Volume 139, Issue 5 , Pages 802-806 , May 2005